• العربية
  • فارسی
BrandBrand
  • Iran Insight
  • Politics
  • Economy
  • Analysis
  • Special Report
  • Opinion
  • Podcast
  • Live TV
  • Iran Insight
  • Politics
  • Economy
  • Analysis
  • Special Report
  • Opinion
  • Podcast
  • Live TV
  • Theme
  • Language
    • العربية
    • فارسی
  • Iran Insight
  • Politics
  • Economy
  • Analysis
  • Special Report
  • Opinion
  • Podcast
  • Live TV
All rights reserved for Volant Media UK Limited
volant media logo

Iran drug stocks under two months, 800 medicines at risk as FX delays bite

Dec 14, 2025, 08:35 GMT+0Updated: 22:46 GMT+0

Iran’s medicine and infant-formula stocks average less than two months, with as many as 800 drug lines at risk of shortage within three months, industry representatives said, citing four-to-five-month delays in foreign-exchange allocation.

Babak Mesbahi, a presidium member of the Iranian Pharmacists Association, said sanctions are indirectly choking payment channels and logistics.

“Based on recent officials’ statements, the country’s medicine reserves on average are less than two months,” he said. “Infant formula faces a similar situation, and about 800 items will face shortages over the next three months.”

Mesbahi told Didban Iran that “Sanctions do not directly target medicine and infant formula, but their side effects are entirely palpable. Currency transfers have become difficult and allocation faces problems, and these issues are directly caused by sanctions.”

Asked whether the government has eased FX transfers, Mesbahi said: “As far as I know, nothing specific has been done. Right now there are pro forma invoices that have remained four to five months in the allocation and transfer queue,” he added.

The end of preferential exchange rates on many imported inputs has accelerated price rises for finished medicines and raw materials, according to pharmacists’ associations.

Hadi Ahmadi, a board member of the Iranian Pharmacists Association, said daily currency volatility and rising input costs are pushing up prices, even for common medicines.

“About 70% of production costs – packaging, auxiliaries and other inputs – follow the free-market exchange rate, and only roughly 30% relates to active ingredients, so price increases are unavoidable,” Ahmadi told ILNA.

“When prices rise and insurance does not keep pace, patients either take incomplete regimens or walk away, and the treatment path is disrupted.”

He added that only two to three million doses of influenza vaccine were imported versus a need of six to seven million for a population near 90 million, and distribution was late, which contributed to wider spread of flu.

Most Viewed

Iran’s nuclear bomb debate gains ground on official platforms
1

Iran’s nuclear bomb debate gains ground on official platforms

2

Iran rejects nuclear talks despite ongoing mediation with US

3

Netanyahu pressing Trump to strike Iran immediately after midterms - Axios

4

Arab states warn Iran of individual, collective retaliation over attacks - WSJ

5

Israel denies pressing Trump for Iran strikes amid diplomatic push

Banner
Banner

Editors' Pick

  • Iran says US tone shifts but demands still block talks

    Iran says US tone shifts but demands still block talks

  • Halloween gathering in Tehran ends in arrests and police crackdown

    Halloween gathering in Tehran ends in arrests and police crackdown

  • Netanyahu or Eisenkot? Tehran sees little difference on war
    INSIGHT

    Netanyahu or Eisenkot? Tehran sees little difference on war

Banner
Banner
Banner
Banner

Spotlight

  • Tehran denies Ghalibaf sidelined as Rezaei's role grows

    Tehran denies Ghalibaf sidelined as Rezaei's role grows

  • Qatar turns to US LNG to cushion Iran war losses

    Qatar turns to US LNG to cushion Iran war losses

  • Mohsen Rezaei’s negotiating calculus: someone else always pays the price
    ANALYSIS

    Mohsen Rezaei’s negotiating calculus: someone else always pays the price

  • Iran’s nuclear bomb debate gains ground on official platforms

    Iran’s nuclear bomb debate gains ground on official platforms

  • Residents describe struggle to afford basic needs as Iran inflation hits 88.7%
    VOICES FROM IRAN

    Residents describe struggle to afford basic needs as Iran inflation hits 88.7%

  • Netanyahu or not, the next move on Iran may be Trump's
    PODCAST

    Netanyahu or not, the next move on Iran may be Trump's

  • New Baha'i memoir recounts life inside Iran's prisons

    New Baha'i memoir recounts life inside Iran's prisons

  • Iran medical suppliers warn of worsening drug shortages

    Iran medical suppliers warn of worsening drug shortages